Archive for the ‘Lyme’ Category

Lactate Dehydrogenase Inhibitors Suppress Bb Growth In Vitro

https://www.mdpi.com/2076-0817/12/7/962

Lactate Dehydrogenase Inhibitors Suppress Borrelia burgdorferi Growth In Vitro

1Department of Microbiology, University of Massachusetts, Amherst, MA 01003, USA
2Department of Biochemistry, University of Massachusetts, Amherst, MA 01003, USA
3Invasive Insect Biocontrol & Behavior Laboratory, USDA-ARS, Beltsville, MD 20705, USA
*
Author to whom correspondence should be addressed.
Pathogens 202312(7), 962; https://doi.org/10.3390/pathogens12070962
Received: 25 June 2023 / Revised: 15 July 2023 / Accepted: 19 July 2023 / Published: 22 July 2023
(This article belongs to the Section Ticks)

Abstract

Borrelia burgdorferi, the causative agent of Lyme disease, has a highly reduced genome and relies heavily on glycolysis for carbon metabolism. As such, established inhibitors of lactate dehydrogenase (LDH) were evaluated in cultures to determine the extent of their impacts on B. burgdorferi growth. Both racemic and enantiopure (AT-101) gossypol, as well as oxamate, galloflavin, and stiripentol, caused the dose-dependent suppression of B. burgdorferi growth in vitro. Racemic gossypol and AT-101 were shown to fully inhibit spirochetal growth at concentrations of 70.5 and 187.5 μM, respectively. Differences between racemic gossypol and AT-101 efficacy may indicate that the dextrorotatory enantiomer of gossypol is a more effective inhibitor of B. burgdorferi growth than the levorotatory enantiomer. As a whole, LDH inhibition appears to be a promising mechanism for suppressing Borrelia growth, particularly with bulky LDH inhibitors like gossypol.  (See link for article)
_______________
**Comment**
Lactate dehydrogenase inhibitors (LDH) are used in various assays for cancer and other research areas. They are also a promising target for cancer therapy.
For more:

FREE Audiobook, Bitten: The Secret History of Lyme Disease and Biological Weapons & The People’s Declaration

https://rumble.com/v3chfwg-bitten.html  Audio Book Here  (Approx. 5 Hours)

Bitten: The Secret History of Lyme Disease and Biological Weapons – Kris Newby – 2019

By: Kris Newby
Narrated by: Coleen Marlo
Unabridged Audiobook

Publisher’s Summary

A riveting thriller reminiscent of The Hot Zone, this true story dives into the mystery surrounding one of the most controversial and misdiagnosed conditions of our time – Lyme disease – and of Willy Burgdorfer, the man who discovered the microbe behind it, revealing his secret role in developing bug-borne biological weapons and raising terrifying questions about the genesis of the epidemic of tick-borne diseases affecting millions of Americans today.

While on vacation on Martha’s Vineyard, Kris Newby was bitten by an unseen tick. That one bite changed her life forever, pulling her into the abyss of a devastating illness that took 10 doctors to diagnose and years to recover: Newby had become one of the 300,000 Americans who are afflicted with Lyme disease each year.  (Recent estimates suggest that 476,000 people get infected with Lyme each year in the U.S.)

As a science writer, she was driven to understand why this disease is so misunderstood and its patients so mistreated. This quest led her to Willy Burgdorfer, the Lyme microbe’s discoverer, who revealed he had developed bug-borne bioweapons during the Cold War and believed that the Lyme epidemic was started by a military experiment gone wrong.

In a superb, meticulous work of narrative journalism, Bitten takes listeners on a journey to investigate these claims, from biological weapons facilities to interviews with biosecurity experts and microbiologists doing cutting-edge research, all the while uncovering darker truths about Willy. It also leads her to uncomfortable questions about why Lyme can be so difficult to both diagnose and treat and why the government is so reluctant to classify chronic Lyme as a disease.

A gripping, infectious pause-resister, Bitten will shed a terrifying new light on an epidemic that is exacting an incalculable toll on us, upending much of what we believe we know about it.

________________

“The fact that the EUUK, and US are currently engaged in projects to sequence nearly 2 million of their citizens’ genomes provides a hint that they may want to collect additional genomes of Africans, Asians, and others.” ~ Dr. Meryl Nass

Experimenting upon innocents has been going on for decades, but the ‘powers that be’ gaslight anyone with an individual thought of their own and shout “misinformation” and “conspiracy theorist” to frighten everyone into mute complacency.  None of it would be possible without academic, political, religious, and scientific communities silently watching and saying nothing.  Evil flourishes when people do nothing.

The People’s Declaration

RIGHT NOW would be a very good time to stand up and publicly declare your opposition to the international plan to share the “benefits” derived from “pathogens with pandemic potential.

https://jamesroguski.substack.com/p/the-peoples-declaration  Go here for videos & information

The United Nations General Assembly is scheduled to adopt a Political Declaration of the United Nations General Assembly High-level Meeting on Pandemic Prevention, Preparedness and Response on September 20, 2023.

YOUR silence on this issue is YOUR consent.

The possibility that these agreements could actually facilitate, fund and support gain-of-function research is absolutely unacceptable. (click on the links below to download the documents)

  1. Political Declaration of the United Nations General Assembly High-level Meeting on Pandemic Prevention, Preparedness and Response
  2. Bureau’s text of the WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response (WHO CA+)
  3. Proposed Amendments to the International Health Regulations (2005) submitted in accordance with decision WHA75(9) (2022)
I encourage YOU to raise your awareness of this issue and help to spread the word far and wide.

For more:

Pregnancy, Breast Feeding & Lyme

https://danielcameronmd.com/pregnancy-breast-feeding-and-lyme/

PREGNANCY, BREAST FEEDING AND LYME

By Dr. Daniel Cameron

Welcome to another selection from my book “An Expert’s Guide on Navigating Lyme disease.” The book highlights the findings of my first 600 Lyme disease Science blogs.  In this episode, I will discuss pregnancy, breast feeding, and Lyme disease.

Pregnancy and breast feeding are particularly concerning topics for Lyme disease patients and their doctors. Here are few findings to help with discussions.

Pregnancy and Lyme.

If a woman is bit by a deer tick or contracts Lyme disease (LD) while pregnant, she must immediately alert her treating physician. Poor outcomes have been described for newborns whose mothers contracted Lyme disease during pregnancy.
 Studies have found that stillbirths occurred when LD was contracted during the first trimester. Markowitz et al., 1986, Schlesinger et al., 1985, and MacDonald et al., 1987) Gestational Lyme borreliosis has been described in 5 of 19 pregnancies (26%) resulting in “syndactyly, cortical blindness, intrauterine fetal death, prematurity, and rash” (Markowitz et al., 1986).

A newborn died at 39 hours of life with a left-sided hypoplastic heart and the presence of spirochetes consistent with Bb [Borrelia burgdorferi] “in the spleen, kidneys, and bone marrow” (Schlesinger et al., 1985). Bb was also cultured from fetal liver tissue in 4 stillborn infants (MacDonald 1986). 
There was insufficient evidence to determine the risk to a child if their mother contracted Lyme disease before pregnancy (Mylonas 2011). A study of 2,000 women with a history of LD did not show an increased risk of fetal death, decreased birth weight, or length of gestation at delivery. There was an increase in the number of congenital defects but the risk may have been by chance alone (Strobino et al., 1993).

Choosing an antibiotic regimen for pregnant women with Lyme disease can be a complex challenge. Amoxicillin, cefuroxime, azithromycin, and IV ceftriaxone have been prescribed for pregnant women (Maraspin et al., 2009).

Author’s note: More studies will be needed to understand pregnancy and breast feeding concerns.

Breast feeding and Lyme.

The CDC addressed the question “Can Lyme disease be transmitted through breast milk?” They announced, “No reports of breast milk spreading Lyme disease to infants exist” (CDC 2022).
There is insufficient data to determine if breastfeeding can transmit Bb to the child. 
Certain antibiotic classes, such as tetracyclines, should not be used in breastfeeding women being treated for Lyme disease to avoid the risk of side effects, such as tooth discoloration. The child’s clinician can help guide treatment options for a breastfeeding mother. Read more.

Diversity of clinical presentations of Lyme and pregnancy.

Doctors followed 11 pregnant women with Lyme disease from 2008 to 2020. “In the present study, we report our case series, which includes 11 pregnant women, 6 of whom developed erythema migrans during pregnancy (between weeks 8 and 34), 3 had monoarticular or neurological symptoms, and 2 had positive serology but did not develop any clinical symptoms” (Trevisan et al., 2020).

All mothers were treated with amoxicillin 1g 3x/ day for 14 days. One child was born prematurely at seven months. Another child was born with angiomatoid patches that regressed spontaneously 18 months later. One of the pregnant women with Lyme disease, confirmed by spinal tap and labs, experienced articular and neurologic involvement and improved with amoxicillin. However, she required treatment with intravenous ceftriaxone because of persistent symptoms. Read more.

Two mothers transmit Lyme to their babies.

Babesia can be contracted from the bite of a deer tick, a blood transfusion, or during pregnancy. This podcast reviews a case in which Babesia was transmitted from mothers to their babies during pregnancy.

Questions raised in the podcast include: 
• How often do mothers contract Babesia from a tick bite during pregnancy?
• Is there an effective and safe treatment for Babesia in pregnant women?
• How does a mother or doctor recognize Babesia in a pregnant mother?
• Should doctors follow pregnant mothers with a tick bite or Lyme disease for Babesia and what evidence should be investigated? 
• Will the mothers develop complications of Babesia in the future if not treated?
• Should the two mothers have been treated for Babesia? Read more.

A baby girl with Lyme disease.

Slovenian researchers investigated whether Borrelia burgdorferi bacteria, the pathogen causing Lyme disease, might impact pregnancy outcomes. 
Pregnancy outcome was unfavorable in 13.8% (42/304) of patients. They found that the outcome of pregnancy in Lyme disease patients was not significantly worse.

There were 22 pre-term births, 10 fetal/perinatal deaths, and/or 15 anomalies. Several mothers had potential explanations for their unfavorable pregnancy outcomes. The poor outcome for Lyme disease patients was not significantly different compared to the general population (Maraspin et al., 2020).

Author’s note: The study did not follow the 262 women who gave birth with a favorable outcome for any long-term problems. Nor did the authors describe the outcome for women who were not treated for early Lyme disease. Read more.

Little information on treatment of tick bites during pregnancy.

Smith et al., (2020) argue that “high-level evidence” supports using a single 200 mg dose of doxycycline for tick bites during pregnancy. The evidence they cited is not high-level. Instead, they focused on a small Meta-Analysis study.
 Regrettably, there is no evidence that a single 200 mg dose of doxycycline prevents other manifestations of Lyme disease, such as heart block, 7th nerve palsy, Lyme arthritis, Lyme encephalopathy, or Neuropsychiatric Lyme disease. Read more.

Congenital transmission of Babesia to a 5-year-old twin.

A baby girl was born to a mother who showed no evidence of Lyme or a related tick-borne illness during her pregnancy (Walker et al., 2022). The 5-week-old female diamniotic dichorionic twin was born at 36 5/7 weeks by C-section and diagnosed with Babesia. Her twin brother was asymptomatic.
The mother described several trips to Cape Cod, Massachusetts, an area endemic to Lyme disease.

“The patient’s mother had one febrile illness during pregnancy, occurring at approximately 23-24 weeks of gestation, associated with a maculopapular rash that resolved spontaneously” (Walter et al., 2022). 
The daughter was treated with a blood transfusion, intravenous atovaquone twice daily, and azithromycin daily. The authors of the article pictured a blood smear with intraerythrocytic inclusions consistent with Babesia microti. Read more.

Delayed onset Babesia in two newborns.

A study from the Mayo clinic described two newborn infants diagnosed with Babesia several weeks after the mothers were treated for Lyme disease (Hoversten and Bartlett, 2018).
 Infant 1:
 A baby boy was diagnosed with Babesia at 4-1/2 weeks. His mother had been diagnosed and treated for early Lyme disease at 32 weeks gestation.  
Infant 2: 
A baby girl was diagnosed with Babesia at 18-days-old. Her mother had been diagnosed and treated for early Lyme disease at 37 weeks gestation.
 Neither mother was treated for Babesia during their pregnancy. Read more.

________________

**Comment**

Lyme/MSIDS has recognized for over 40 years, yet very little has been done relating to pregnancy, breastfeeding, effective treatments, persistence, and transmission.  The fact so much work on supposed ‘climate change’ should prove to anyone with a functioning brain that something isn’t right.  While thousands suffer, the only thing we have to show for it is mountains of data on ticks and the climate, despite independent research proving ticks are marvelously ecoadaptive as well as pointing out erroneous, biased, shoddy research being used to support a faulty model to push a climate narrative.

The fact that infected moms have had babies die, and the fact they have cultured spirochetes in the heart, liver, spleen, kidneys, and bone marrow of infants should raise alarming red flags.

Regarding the CDC’s statement on breastfeeding – just because something hasn’t been reported, doesn’t mean it doesn’t happen.

Any red flags simply get buried under climate data.  

For more:

Case Report: Substantial Improvement of Autism in Child By Using Treatment For Vector Borne Infections

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1205545/full

Case report: Substantial improvement of autism spectrum disorder in a child with learning disabilities in conjunction with treatment for poly-microbial vector borne infections

CASE REPORT article

Front. Psychiatry, 18 August 2023
Sec. Autism
Volume 14 – 2023 | https://doi.org/10.3389/fpsyt.2023.1205545
  • 1Heart and Soul Integrative Health, Marble Falls, TX, United States
  • 2Intracellular Pathogens Research Laboratory, Department of Clinical Sciences, and the Comparative Medicine Institute, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, United States

Poly-microbial vector-borne infections may have contributed to neuropsychiatric symptoms in a boy diagnosed with autism spectrum disorder. Targeted antimicrobial treatment resulted in substantial improvement in cognitive (such as learning disabilities, focus, concentration) and neurobehavioral (such as oppositional, defiant, anti-social, disordered mood, immaturity, tics) symptoms.

Conclusion

This teenage boy had a drastic improvement in his neuropsychiatric symptoms and in his academic standing, moving from special education services with accommodations to grade level academic standing without accommodations, to college acceptance. Progressive symptomatic improvement occurred only following targeted administration of antimicrobial agents directed at suspected, underlying, chronic infectious pathogens, namely the causative agents of bartonellosis and borreliosis. Further research is clearly needed to define if or the extent to which occult infections can contribute to neuropsychiatric illness, such as ASD.

(See link for full article)

_________________

For more:

The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses

https://www.mdpi.com/2076-2607/11/7/1759

The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses

By Samuel M. Shor and Sunjya K. Schweig

Microorganisms 202311(7), 1759; https://doi.org/10.3390/microorganisms11071759
Received: 14 May 2023 / Revised: 29 June 2023 / Accepted: 29 June 2023 / Published: 5 July 2023

Abstract

The primary objective of this paper is to provide an evidence-based update of the literature on the use of bioactive phytochemicals, nutraceuticals, and micronutrients (dietary supplements that provide health benefits beyond their nutritional value) in the management of persistent cases of Borrelia burgdorferi infection (Lyme disease) and two other tick-borne pathogens, Babesia and Bartonella species. Recent studies have advanced our understanding of the pathophysiology and mechanisms of persistent infections. These advances have increasingly enabled clinicians and patients to utilize a wider set of options to manage these frequently disabling conditions. This broader toolkit holds the promise of simultaneously improving treatment outcomes and helping to decrease our reliance on the long-term use of pharmaceutical antimicrobials and antibiotics in the treatment of tick-borne pathogens such as Borrelia burgdorferiBabesia, and Bartonella (See link for full article)
___________________
Go here for an excellent article on the above study which breaks it down for the lay person.  The following graph is within the article and will interest you:

For a full list of all 30+ bioactive nutraceuticals, see Appendix A. Summary of Clinical Impact.

For more: